Your browser doesn't support javascript.
loading
Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation.
Ramachandran, Anassuya; Mehic, Merima; Wasim, Laabiah; Malinova, Dessislava; Gori, Ilaria; Blaszczyk, Beata K; Carvalho, Diana M; Shore, Eileen M; Jones, Chris; Hyvönen, Marko; Tolar, Pavel; Hill, Caroline S.
Afiliación
  • Ramachandran A; Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
  • Mehic M; Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
  • Wasim L; Immune Receptor Activation Laboratory, The Francis Crick Institute, London, UK.
  • Malinova D; Immune Receptor Activation Laboratory, The Francis Crick Institute, London, UK.
  • Gori I; Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
  • Blaszczyk BK; Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Carvalho DM; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, UK.
  • Shore EM; Departments of Orthopaedic Surgery and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Jones C; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, UK.
  • Hyvönen M; Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Tolar P; Immune Receptor Activation Laboratory, The Francis Crick Institute, London, UK.
  • Hill CS; Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
EMBO J ; 40(14): e106317, 2021 07 15.
Article en En | MEDLINE | ID: mdl-34003511

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosforilación / Activinas / Receptores de Activinas Tipo I Límite: Animals / Humans Idioma: En Revista: EMBO J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosforilación / Activinas / Receptores de Activinas Tipo I Límite: Animals / Humans Idioma: En Revista: EMBO J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido